Search research articles
Contact Us
Filters
Showing results (61-70 of 124) with videos related to
Page
of 13
Sort By:
International Journal of Oncology
|
July 25, 2020
Endoplasmic reticulum stress, unfolded protein response and autophagy contribute to resistance to glucocorticoid treatment in human acute lymphoblastic leukaemia cells
Sangkab Sudsaward, Sasiprapa Khunchai, Chutamas Thepmalee, et al.
Mutation Research
|
April 19, 2008
Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases
Monica Neri, Donatella Ugolini, Irma Dianzani, et al.
American Journal of Respiratory Cell and Molecular Biology
|
June 9, 2009
MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications
Sara Busacca, Serena Germano, Loris De Cecco, et al.
Cancer Research
|
August 4, 2018
A Polysome-Based microRNA Screen Identifies miR-24-3p as a Novel Promigratory miRNA in Mesothelioma
Stefania Oliveto, Roberta Alfieri, Annarita Miluzio, et al.
Clinical Genitourinary Cancer
|
May 14, 2026
Comparative and Critical Analysis of Immune-based Combinations for First-line Treatment of Metastatic Renal Cell Carcinoma
Tomer Meirson, Luciano Mutti, Daniel A Goldstein, et al.
Journal of Translational Medicine
|
October 15, 2018
p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification
Kun Tian, Emyr Bakker, Michelle Hussain, et al.
Cancer Research
|
October 3, 2002
High frequency of micronuclei in peripheral blood lymphocytes as index of susceptibility to pleural malignant mesothelioma
Claudia Bolognesi, Rosangela Filiberti, Monica Neri, et al.
Stem Cell Research & Therapy
|
May 27, 2017
The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells
Alessandra Pattarozzi, Elisa Carra, Roberto E Favoni, et al.
International Journal of Molecular Medicine
|
January 15, 2003
Transforming growth factor-beta released by PPD-presenting malignant mesothelioma cells inhibits interferon-gamma synthesis by an anti-PPD CD4+ T-cell clone
Maria Teresa Valle, Camillo Porta, Anna Maria Megiovanni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma
Andrea Sartore-Bianchi, Fabio Gasparri, Arturo Galvani, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 124) with videos related to
Sort By:
Page
of 13
International Journal of Oncology
|
July 25, 2020
Endoplasmic reticulum stress, unfolded protein response and autophagy contribute to resistance to glucocorticoid treatment in human acute lymphoblastic leukaemia cells
Sangkab Sudsaward, Sasiprapa Khunchai, Chutamas Thepmalee, et al.
Mutation Research
|
April 19, 2008
Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases
Monica Neri, Donatella Ugolini, Irma Dianzani, et al.
American Journal of Respiratory Cell and Molecular Biology
|
June 9, 2009
MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications
Sara Busacca, Serena Germano, Loris De Cecco, et al.
Cancer Research
|
August 4, 2018
A Polysome-Based microRNA Screen Identifies miR-24-3p as a Novel Promigratory miRNA in Mesothelioma
Stefania Oliveto, Roberta Alfieri, Annarita Miluzio, et al.
Clinical Genitourinary Cancer
|
May 14, 2026
Comparative and Critical Analysis of Immune-based Combinations for First-line Treatment of Metastatic Renal Cell Carcinoma
Tomer Meirson, Luciano Mutti, Daniel A Goldstein, et al.
Journal of Translational Medicine
|
October 15, 2018
p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification
Kun Tian, Emyr Bakker, Michelle Hussain, et al.
Cancer Research
|
October 3, 2002
High frequency of micronuclei in peripheral blood lymphocytes as index of susceptibility to pleural malignant mesothelioma
Claudia Bolognesi, Rosangela Filiberti, Monica Neri, et al.
Stem Cell Research & Therapy
|
May 27, 2017
The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells
Alessandra Pattarozzi, Elisa Carra, Roberto E Favoni, et al.
International Journal of Molecular Medicine
|
January 15, 2003
Transforming growth factor-beta released by PPD-presenting malignant mesothelioma cells inhibits interferon-gamma synthesis by an anti-PPD CD4+ T-cell clone
Maria Teresa Valle, Camillo Porta, Anna Maria Megiovanni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma
Andrea Sartore-Bianchi, Fabio Gasparri, Arturo Galvani, et al.
Page
of 13